BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28344602)

  • 1. Safety and outcome of external beam radiation and neutron brachytherapy in elderly patients with esophageal squamous cell cancer.
    Li T; Zhang W; Lv J; Liu H; Wang Q; Jia X; Liu B; Lang J
    J Contemp Brachytherapy; 2017 Feb; 9(1):36-43. PubMed ID: 28344602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External beam radiation and high-dose-rate brachytherapy for elderly patients with gastroesophageal junction adenocarcinoma.
    Zhang W; Wang Q; Li T; Lv J; Liu H; Jia X; Liu B; Fan Y; Wang Y; Wang J; Wu L; Lang J
    J Contemp Brachytherapy; 2017 Aug; 9(4):330-337. PubMed ID: 28951752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective study of external beam radiation, neutron brachytherapy, and concurrent chemotherapy for patients with localized advanced carcinoma of the esophagus.
    Ma K; Wang Q; Li T; Liu H; Liu B; Jia X; Li S; Lang J; Zhang M
    Radiat Oncol; 2014 Dec; 9():294. PubMed ID: 25515326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Californium-252 neutron brachytherapy combined with external beam radiotherapy for esophageal cancer: long-term treatment results.
    Liu H; Wang Q; Wan X; Jia X; Liu B; Wang CK
    Brachytherapy; 2014; 13(5):514-21. PubMed ID: 24818780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External beam radiotherapy with or without californium-252 neutron brachytherapy for treatment of recurrence after definitive chemoradiotherapy.
    Wu WA; Yang YP; Liang J; Zhao J; Wang JS; Zhang J
    Sci Rep; 2020 Dec; 10(1):20902. PubMed ID: 33262384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective study of californium-252 neutron brachytherapy combined with EBRT versus 3D-CRT in the treatment of esophageal squamous cell cancer.
    Wang Q; Li T; Lang J; Wang J; Wang J; Liu H; Jia X; Liu B; Wang CK
    Radiat Oncol; 2015 Oct; 10():212. PubMed ID: 26499111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined neutron brachytherapy with external beam radiation in patients with inoperable gastroesophageal junction adenocarcinoma.
    Wang Q; Liu H; Jia X; Liu B; Wan X
    Tumori; 2014; 100(4):470-5. PubMed ID: 25296599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of external beam radiotherapy and Californium (Cf)-252 neutron intracavity brachytherapy is more effective in control of cervical squamous cell carcinoma than that of cervical adenocarcinoma.
    Xiong Y; Liu J; Chen S; Zhou Q; Xu W; Tang C; Chen Y; Yang M; Lei X
    Med Oncol; 2015 Sep; 32(9):231. PubMed ID: 26271794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early-stage esophageal squamous cell carcinoma treated with californium-252 neutron brachytherapy: clinical report on 16 cases.
    Liu H; Wang Q; Jia X; Liu B; Wang CK
    Tumori; 2013; 99(2):172-5. PubMed ID: 23748810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Follow-up study of clinical effects of californium-252 neutron intracavitary radiotherapy and external beam radiotherapy in endometrial cancer].
    Lei X; Shan JL; Tang C; Zhao KW
    Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):733-6. PubMed ID: 18307897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.
    Zhang M; Xu HD; Pan SD; Lin S; Yue JH; Liu JR
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):966-71. PubMed ID: 22138462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxic versus normoxic external-beam irradiation of cervical carcinoma combined with californium-252 neutron brachytherapy. Comparative treatment results of a 5-year randomized study.
    Tacev T; Vacek A; Ptácková B; Strnad V
    Strahlenther Onkol; 2005 May; 181(5):273-84. PubMed ID: 15900423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.
    Lee SW; Suh CO; Chung EJ; Kim GE
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1338-44. PubMed ID: 11955747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Californium-252 brachytherapy combined with external-beam radiotherapy for cervical cancer: long-term treatment results.
    Lei X; Qian CY; Qing Y; Zhao KW; Yang ZZ; Dai N; Zhong ZY; Tang C; Li Z; Gu XQ; Zhou Q; Feng Y; Xiong YL; Shan JL; Wang D
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1264-70. PubMed ID: 21435797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric parameters that predict late rectal complications after curative radiotherapy in patients with uterine cervical carcinoma.
    Hyun Kim T; Choi J; Park SY; Lee SH; Lee KC; Yang DS; Shin KH; Cho KH; Lim HS; Kim JY
    Cancer; 2005 Sep; 104(6):1304-11. PubMed ID: 16078262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dose-rate brachytherapy for elderly patients with uterine cervical cancer.
    Chen SW; Liang JA; Yang SN; Lin FJ
    Jpn J Clin Oncol; 2003 May; 33(5):221-8. PubMed ID: 12865465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule.
    Toita T; Kakinohana Y; Ogawa K; Adachi G; Moromizato H; Nagai Y; Maehama T; Sakumoto K; Kanazawa K; Murayama S
    Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1344-53. PubMed ID: 12873679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: clinical experience with and without chemotherapy.
    Sood BM; Gorla G; Gupta S; Garg M; Deore S; Runowicz CD; Fields AL; Goldberg GL; Anderson PS; Vikram B
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):702-6. PubMed ID: 12062615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.